SCHEMBL3360967

SCHEMBL3360967

O=C1NC(=S)SC1=Cc1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.82
INSR P06213 4/20 0.69
IGF1R P08069 4/20 0.69
PIK3CG P48736 1/20 0.67
PTP4A3 O75365 1/20 0.64
PTPN5 P54829 1/20 0.63
KMT2A Q03164 7/20 0.62
MEN1 O00255 6/20 0.62
POLB P06746 6/20 0.62
TDP1 Q9NUW8 5/20 0.62
ALDH1A1 P00352 4/20 0.62
MAPT P10636 4/20 0.62
RECQL P46063 3/20 0.62
MCL1 Q07820 2/20 0.62
NPSR1 Q6W5P4 2/20 0.62
EIF4E P06730 1/20 0.62
EIF4G1 Q04637 1/20 0.62
THRB P10828 1/20 0.62
L3MBTL1 Q9Y468 5/20 0.61
NPC1 O15118 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12989661 1.00 TTR (0.82) TTRINSRIGF1RPIK3CGPTP4A3
SCHEMBL30657767 1.00 TTR (0.82) TTRINSRIGF1RPIK3CGPTP4A3
SCHEMBL3360964 1.00 TTR (0.82) TTRINSRIGF1RPIK3CGPTP4A3
SCHEMBL12156076 0.90 TTR (1.00) TTRINSRIGF1RPIK3CGPTPN5
SCHEMBL6387049 0.88 INSR (0.82) TTRINSRIGF1RPIK3CGPTP4A3
SCHEMBL6387045 0.88 INSR (0.82) TTRINSRIGF1RPIK3CGPTP4A3
SCHEMBL3892565 0.88 HSPD1 (0.71) TTRINSRIGF1RPIK3CGPTP4A3
SCHEMBL3892559 0.88 HSPD1 (0.71) TTRINSRIGF1RPIK3CGPTP4A3
SCHEMBL5124788 0.87 IGF1R (0.80) TTRINSRIGF1RPIK3CGPTP4A3
SCHEMBL14277839 0.87 IGF1R (0.80) TTRINSRIGF1RPIK3CGPTP4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100331315-A1 RHODANINES AND RELATED HETEROCYCLES AS KINASE INHIBITORS SENHWA BIOSCIENCES, INC. (TW) 2010-12-30 US disclosed
WO-2010148351-A1 RHODANINES AND RELATED HETEROCYCLES AS KINASE INHIBITORS CYLENE PHARMACEUTICALS, INC. (US) 2010-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331315-A1 RHODANINES AND RELATED HETEROCYCLES AS KINASE INHIBITORS PIM2, PIM1, CDK2 TTR 4754/4885INSR 1642/4885IGF1R 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.